Form D Explorer

Inspect source fieldsReport a record issue

Form D — Vesalius Longevity Labs Inc.

0001062993-26-006173 · filed Nov 18, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$13,464,278
Reported amount sold
$6,499,999
Minimum investment
$0
Investors
9
Sales commission
$0
Finders' fees
$0

Issuer

Name
Vesalius Longevity Labs Inc.
CIK
2131865
Entity
Corporation
Jurisdiction
BRITISH COLUMBIA, CANADA
Year incorporated
—
Address
1500-1055 WEST GEORGIA STREET
VANCOUVER, British Columbia, Canada V6E 4N7
Phone
507-666-6151

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗